Order Article Reprints

Serna-Higuita LM, Amaral T, Forschner A, Leiter U, Flatz L, Seeber O, Thomas I, Garbe C, Eigentler TK, Martus P. Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry. Cancers. 2021; 13(23):6141. https://doi.org/10.3390/cancers13236141

Serna-Higuita, Lina María, Teresa Amaral, Andrea Forschner, Ulrike Leiter, Lukas Flatz, Olivia Seeber, Ioannis Thomas, Claus Garbe, Thomas Kurt Eigentler, and Peter Martus. 2021. "Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry" Cancers 13, no. 23: 6141. https://doi.org/10.3390/cancers13236141

Serna-Higuita, L. M., Amaral, T., Forschner, A., Leiter, U., Flatz, L., Seeber, O., Thomas, I., Garbe, C., Eigentler, T. K., & Martus, P. (2021). Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry. Cancers, 13(23), 6141. https://doi.org/10.3390/cancers13236141